Matches in SemOpenAlex for { <https://semopenalex.org/work/W3123427197> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W3123427197 endingPage "385" @default.
- W3123427197 startingPage "385" @default.
- W3123427197 abstract "385 Background: We aimed to compare chemotherapy regimens used and overall survival (OS) among geriatric patients (≥ 75 years) with APC as compared to old (65-74 years) and young (< 65 years) patients with APC. Methods: In this retrospective population-based analysis, we identified patients with APC (defined as inoperable/metastatic disease) from 5 large provinces in Canada who were diagnosed from 2011 to 2016. Kaplan-Meier curves were plotted to derive OS and multivariable Cox regression models were constructed to determine the associations of different age groups on OS. Results: We included 636 patients diagnosed with APC of whom 258 (40.6%), 247 (38.8%) and 131 (20.6%) were young, old and geriatric. Approximately half (45.7%) of all patients were women. Eastern Cooperative Oncology Group performance status (ECOG PS) was known in 508 patients at diagnosis among whom 62.2% were 0-1 and 37.8% were 2+. ECOG PS was more likely to be 2+ in the geriatric group (46.8% vs 41.1% vs 31.3%; P = 0.017). Most patients (95.8%) had metastatic disease while the remaining patients had inoperable locally advanced disease. Within the study cohort, 38.7% received chemotherapy. Treatment rates differed based on age: 41.9% in young patients, 40.9% in old patients and 28.2% in geriatric patients (P = 0.02). Choice of first-line chemotherapy varied and included FOLFIRINOX (F) in 99 (40.2%), gemcitabine and nab-paclitaxel (GN) in 91 (37.0%) and gemcitabine (G) in 56 (22.8%). F, GN and G were administered in 27.0%, 32.4% and 40.5% of geriatric patients, 40.6%, 32.7% and 26.7% of old patients, and 44.4%, 42.6% and 13.0% of young patients, respectively (P = 0.007). After adjusting for baseline factors, both geriatric (odds ratio [OR], 0.70; 95% confidence interval [CI], 0.42-1.17; P = 0.175) and old patients were as likely to receive chemotherapy (OR, 1.04; 95% CI, 0.70-1.56; P = 0.815) as their young counterparts. The median OS was 7.1 (6.3-8.4), 6.7 (5.5-8.9) and 5.3 (4.3-6.8) months in young, old and geriatric patients, respectively. After adjusting for baseline variables, both geriatric (hazard ratio [HR], 1.25; 95% CI, 0.96-1.62; P = 0.101) and old patients (HR, 1.16; 95% CI, 0.94-1.42; P = 0.171) experienced similar OS as young patients. ECOG PS 2+ at presentation was associated with worse OS as was treatment with G. Conclusions: Overall treatment rates for APC are low in the real world. The poor OS in geriatric patients with APC is driven by poor PS and use of less intensive chemotherapy. Age alone should not be considered a contraindication for more intensive chemotherapy since treatment benefit is observed across all age groups. [Table: see text]" @default.
- W3123427197 created "2021-02-01" @default.
- W3123427197 creator A5014239053 @default.
- W3123427197 creator A5016636327 @default.
- W3123427197 creator A5039850848 @default.
- W3123427197 creator A5055984590 @default.
- W3123427197 creator A5060573575 @default.
- W3123427197 creator A5064788800 @default.
- W3123427197 creator A5075972279 @default.
- W3123427197 creator A5076311536 @default.
- W3123427197 date "2021-01-20" @default.
- W3123427197 modified "2023-09-24" @default.
- W3123427197 title "Treatment patterns and survival outcomes of older patients with advanced pancreatic cancer (APC): A Canadian real-world evidence study." @default.
- W3123427197 doi "https://doi.org/10.1200/jco.2021.39.3_suppl.385" @default.
- W3123427197 hasPublicationYear "2021" @default.
- W3123427197 type Work @default.
- W3123427197 sameAs 3123427197 @default.
- W3123427197 citedByCount "1" @default.
- W3123427197 countsByYear W31234271972021 @default.
- W3123427197 crossrefType "journal-article" @default.
- W3123427197 hasAuthorship W3123427197A5014239053 @default.
- W3123427197 hasAuthorship W3123427197A5016636327 @default.
- W3123427197 hasAuthorship W3123427197A5039850848 @default.
- W3123427197 hasAuthorship W3123427197A5055984590 @default.
- W3123427197 hasAuthorship W3123427197A5060573575 @default.
- W3123427197 hasAuthorship W3123427197A5064788800 @default.
- W3123427197 hasAuthorship W3123427197A5075972279 @default.
- W3123427197 hasAuthorship W3123427197A5076311536 @default.
- W3123427197 hasConcept C121608353 @default.
- W3123427197 hasConcept C126322002 @default.
- W3123427197 hasConcept C143998085 @default.
- W3123427197 hasConcept C167135981 @default.
- W3123427197 hasConcept C2776694085 @default.
- W3123427197 hasConcept C2776907518 @default.
- W3123427197 hasConcept C2777148230 @default.
- W3123427197 hasConcept C2777319248 @default.
- W3123427197 hasConcept C2780210213 @default.
- W3123427197 hasConcept C2780258809 @default.
- W3123427197 hasConcept C2780259306 @default.
- W3123427197 hasConcept C50382708 @default.
- W3123427197 hasConcept C526805850 @default.
- W3123427197 hasConcept C71924100 @default.
- W3123427197 hasConcept C72563966 @default.
- W3123427197 hasConceptScore W3123427197C121608353 @default.
- W3123427197 hasConceptScore W3123427197C126322002 @default.
- W3123427197 hasConceptScore W3123427197C143998085 @default.
- W3123427197 hasConceptScore W3123427197C167135981 @default.
- W3123427197 hasConceptScore W3123427197C2776694085 @default.
- W3123427197 hasConceptScore W3123427197C2776907518 @default.
- W3123427197 hasConceptScore W3123427197C2777148230 @default.
- W3123427197 hasConceptScore W3123427197C2777319248 @default.
- W3123427197 hasConceptScore W3123427197C2780210213 @default.
- W3123427197 hasConceptScore W3123427197C2780258809 @default.
- W3123427197 hasConceptScore W3123427197C2780259306 @default.
- W3123427197 hasConceptScore W3123427197C50382708 @default.
- W3123427197 hasConceptScore W3123427197C526805850 @default.
- W3123427197 hasConceptScore W3123427197C71924100 @default.
- W3123427197 hasConceptScore W3123427197C72563966 @default.
- W3123427197 hasIssue "3_suppl" @default.
- W3123427197 hasLocation W31234271971 @default.
- W3123427197 hasOpenAccess W3123427197 @default.
- W3123427197 hasPrimaryLocation W31234271971 @default.
- W3123427197 hasRelatedWork W2074496248 @default.
- W3123427197 hasRelatedWork W2599910524 @default.
- W3123427197 hasRelatedWork W3045328550 @default.
- W3123427197 hasRelatedWork W3092133951 @default.
- W3123427197 hasRelatedWork W3092476531 @default.
- W3123427197 hasRelatedWork W3154040450 @default.
- W3123427197 hasRelatedWork W3196960728 @default.
- W3123427197 hasRelatedWork W3206817346 @default.
- W3123427197 hasRelatedWork W4298126264 @default.
- W3123427197 hasRelatedWork W4307429747 @default.
- W3123427197 hasVolume "39" @default.
- W3123427197 isParatext "false" @default.
- W3123427197 isRetracted "false" @default.
- W3123427197 magId "3123427197" @default.
- W3123427197 workType "article" @default.